The Cell & Gene Therapy Manufacturing & Commercialization event in the United States focuses on the manufacturing and commercialization aspects of cell and gene therapies. The #1 cell & gene conference bringing together 300+ leaders from pharma and biotech. The event would likely showcase the latest advancements in cell and gene therapy manufacturing processes, technologies, and equipment. Experts might discuss topics such as automation, scale-up strategies, quality control, and cost-effective manufacturing approaches. Discussions might also cover cell and gene therapy manufacturing challenges and potential solutions. Sessions at the event would explore strategies for successfully commercializing cell and gene therapies in the United States. Topics could include market access, pricing and reimbursement considerations, regulatory pathways, intellectual property protection, and market dynamics. Industry leaders and experts might share their experiences, case studies, and insights on navigating the complex commercialization landscape. The event would likely delve into supply chain management considerations.
Continue reading at informaconnect.com
September 18 to September 21, 2023
Boston Convention and Exhibition Center,415 Summer Street, Boston, Massachusetts 02210, United States of America.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2023 Netspective Media LLC. All Rights Reserved.
Built on Jun 5, 2023 at 1:40pm